| Patent Number |
Title Of Patent |
Date Issued |
| 6919086 |
Graminae pollen allergen mutants for specific immunotherapy, and production and use of the same |
July 19, 2005 |
| The invention relates to modified recombinant allergen mutants which can be obtained from recombinant allergens which are derived from allergens which can be obtained by extraction from natural raw materials such as pollen of the species Phleum pratense. While these modified recombinant |
| 6805923 |
Liquid-crystalline medium |
October 19, 2004 |
| A liquid-crystalline medium based on a mixture of polar compounds having positive dielectric anisotropy, characterized in that it comprises one or more compounds of the general formula I ##STR1##in which R, A, L.sup.1, L.sup.2 and Y are as defined herein are suitable for use in li |
| 6764722 |
Liquid-crystalline medium |
July 20, 2004 |
| The invention relates to a liquid-crystalline medium based on a mixture of polar compounds of negative dielectric anisotropy which comprises at least one compound of the formula I1 ##STR1##and at least one compound of the formula I2 ##STR2##in which R.sup.11, R.sup.12, R.sup.21 an |
| 6677003 |
Liquid-crystalline medium |
January 13, 2004 |
| A liquid-crystalline medium based on a mixture of polar compounds of positive dielectric anisotropy, characterized in that it comprises one or more compounds of the formula I ##STR1##and one or more compounds of the formula IA ##STR2##in which ##STR3##are as defined herein, is su |
| 6676857 |
Mono-, oligo- and poly-4-fluorothiophenes and their use as charge transport materials |
January 13, 2004 |
| Mono-, oligo- and polymers comprising one or more identical or different recurring units of formula IwhereinD is a 3-substituted-4-fluorothiophene group of formula II, ##STR1##wherein Y, Z, R.sup.1, a, b and c have the meanings defined herein, are useful as semiconductors or charge trans |
| 6641871 |
Liquid-crystal compound, liquid-crystal medium comprising same, and electro-optical liquid-cryst |
November 4, 2003 |
| The present invention relates to compounds containing a cyclobutanone group of the formula I ##STR1##where the various parameters are as defined in the text, and to liquid-crystal media which comprise these compounds, and to their use in electro-optical displays, in particular in PA |
| 6638581 |
Liquid-crystal medium, and electro-optical display containing the medium |
October 28, 2003 |
| A liquid-crystal medium comprising a) at least one compound of the formula I and b) at least one compound of the formula II ##STR1## wherein R.sup.11, R.sup.12, R.sup.21, R.sup.22, A.sup.1, A.sup.21, Z.sup.21, Z.sup.22, L.sup.21, L.sup.22 and I are as defined herein are suitable f |
| 6602562 |
Electro-optical liquid-crystal display |
August 5, 2003 |
| The invention generally relates to an electro-optical liquid-crystal display having a re-alignment layer, for re-aligning the liquid crystals, whose field has a component parallel to the liquid-crystal layer which is desirable for the re-alignment, including a liquid-crystalline medium o |
| 6559144 |
Bicyclic amino acids |
May 6, 2003 |
| Compounds of the formula I ##STR1##in which X, Y, Z, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.7, R.sup.8, R.sup.11, m and n have the meanings stated in claim 1, and their physiologically acceptable salts can be used as integrin inhibitors, in particular for the prophylax |
| 6551666 |
Cyclohexane derivatives and liquid-crystalline medium |
April 22, 2003 |
| The invention relates to cyclohexane derivatives of the formula I ##STR1##in which n, m, p, R.sup.1, X.sup.1, X.sup.2, Z.sup.1, Z.sup.2, Z.sup.3, A.sup.1 A.sup.2 and Y are as defined above. |
| 6534478 |
Cyclic azapeptides with angiogenic effect |
March 18, 2003 |
| Compounds of the formula Iin which aArg, aGly, aAsp, aX and aY have the meanings indicated in claim 1,and their salts,can be used as integrin inhibitors, in particular for the prophylaxis and treatment of diseases of the circulation, in thrombosis, cardiac infarct, coronary heart disease |
| 6514524 |
Orally administerable immediate-release and prolonged-release galenic form comprising an absorpt |
February 4, 2003 |
| The present invention relates to an orally administrable galenic formulation allowing improved absorption by the transmembrane or paracellular route in the gastrointestinal tract of active ingredients which are hydrophilic or ionizable in physiological media. The galenic formulation |
| 6509499 |
Nitromethylthiobenzene derivatives as inhibitors of aldose reductase |
January 21, 2003 |
| The invention concerns novel compound of general formula (1) in which: P, T.sub.1, T.sub.2, X and n are as defined in claim 1, their tautomeric forms, and their additive salts with pharmaceutically acceptable bases. The invention also concerns methods for preparing these compounds and |
| 6491930 |
Stable cosmetic formulation containing butylmethoxydibenzoylmethane |
December 10, 2002 |
| The invention relates e.g. to the use of aldehydes and/or ketones for improving the stability of cosmetic formulations containing butylmethoxydibenzoylmethane as organic light protection filters in conjunction with inorganic light protection filters. |
| 6479302 |
Method for the immunological determination of an analyte |
November 12, 2002 |
| The invention concerns a method for the immunological determination of an analyte in a sample using magnetic particles coated with the analyte to be determined or analyte-specific bonding partners and directly detectable non-magnetic particles coated with analyte-specific bonding partner |
| 6478967 |
Removal of contaminants from biological products |
November 12, 2002 |
| The invention relates to methods for separating biological contaminants (viruses, nucleic acids and/or endotoxins) from biological products, or for reducing the content of such biological contaminants in said biological products. The sample (biological product) to be purified is trea |
| 6457855 |
Micro mixer |
October 1, 2002 |
| A micro mixer for liquid, viscous or gaseous phases with two adjacent housing parts (1,2) disposed on a parting plane (3). Capillary tubes (7) forming line connections are inserted into cross holes (6) in the top part of the housing (1) by welding, for instance, and run into the parting |
| 6457854 |
Micromixer |
October 1, 2002 |
| The inventive micromixer for mixing liquid, viscous or gaseous phases has a housing bottom part (2) and a housing top part (3) which lie closely against each other via connecting surfaces (6, 7). Two delivery channels (1a, 1b) and an outlet channel (5) open out into the dividing surface |
| 6426087 |
Orally administrable immediate-release and prolonged-release galenic form comprising an absorpti |
July 30, 2002 |
| The present invention relates to an orally administrable galenic form allowing improved absorption by the transmembrane or paracellular route in the gastrointestinal tract of active ingredients which are hydrophilic or ionizable in physiol. media, comprising at least one such active |
| 6399044 |
Skin-coloring powder mixture |
June 4, 2002 |
| The invention related to powder mixtures containing formaldehyde- and/or formic acid-releasing compounds which have skin-tanning properties, which powder mixtures contain an agent which forms sulphite ions and, if appropriate, a stabilizer, and to the preparation and use of these powder |
| 6326403 |
Diacylhydrazine derivatives as integrin inhibitors |
December 4, 2001 |
| Compounds of the formula I ##STR1##wherein X, Y, Z, R.sup.1 and R.sup.2 are as defined in claim 1, and their salts and solvates, can be used as integrin inhibitors in particular for the prophylaxis and treatment of circulatory disorders, for thrombosis, cardiac infarction, coronary h |
| 6296793 |
Composition for preparing water-repellent coatings on optical substrates |
October 2, 2001 |
| Composition for preparing water-repellent coatings on optical substrates, comprising a porous, electrically conductive molding and an organosilicon compound, obtainable by mixing an electrically conductive or semiconductive support material with a binder and subjecting the mixture to |
| 6036884 |
Liquid-crystalline medium |
March 14, 2000 |
| The invention relates to a liquid-crystalline medium based on a mixture of polar compounds having positive dielectric anisotropy, characterized in that it comprises one or more compounds of the general formula I ##STR1## and simultaneously one or more compounds of the general formula |
| 5993692 |
Liquid-crystalline medium |
November 30, 1999 |
| The invention relates to a liquid-crystalline medium based on a mixture of polar compounds having positive dielectric anisotropy, characterized in that it comprises one or more compounds of the formula I ##STR1## and one or more compounds of the formula I.sup.* ##STR2## in wh |
| 5993691 |
Electro-optical liquid crystal display |
November 30, 1999 |
| The invention relates to an electro-optical liquid-crystal display having a realignment layer for realigning the liquid crystals whose field has a significant component parallel to the liquid-crystal layer and which contains a liquid-crystalline medium of positive dielectric anisotropy, |
| 5932765 |
Nitromethyl ketones, process for preparing them and compositions containing them |
August 3, 1999 |
| The present invention relates to the compounds of formula: ##STR1## in which R.sub.1, R.sub.2, R.sub.3, E, A, X, Z, p and n are as defined herein. These compounds are aldose reductase inhibitors. |
| 5932415 |
Processes and agents for detecting listerias |
August 3, 1999 |
| The invention relates to agents and processes for detecting bacteria of the genus Listeria, in particular L. monocytogenes. The agents according to the invention include primers whose sequence is selected from the iap gene of L. monocytogenes. In addition, the agents according to the inv |
| 4130502 |
Liquid crystalline cyclohexane derivatives |
December 19, 1978 |
| Novel liquid crystals have the formula ##STR1## wherein one of R.sub.1 and R.sub.2 is cyano and the other is R, OR, OCOR or OCOOR, in which R is alkyl containing up to 12 carbon atoms.The novel compounds can be used alone and in mixtures with each other and/or other conventional liqu |